SEC CIK 1134657
EVNIN LUKE
Reported ownership across 5 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| TMUSview stock → | 6,777,876 | 2007-04-24 |
| RIGLview stock → | 4,340,278 | 2003-06-26 |
| RYTMview stock → | 2,596,392 | 2017-10-10 |
| VSTMview stock → | 1,933,333 | 2012-02-01 |
| PCRXview stock → | 0 | 2013-06-13 |
Position History — PCRX
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — PCRX
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2013-06-13 | Open-market sale | 20,311 | $30.07 | 0 |
| 2013-06-12 | Grant / award (derivative) | 7,000 | $0.00 | 7,000 |
| 2013-06-12 | Open-market sale | 2,435 | $30.00 | 20,311 |
| 2013-06-03 | Open-market sale | 82,072 | $30.00 | 824,255 |
| 2013-05-31 | Open-market sale | 9,935 | $30.00 | 906,327 |
| 2013-05-30 | Open-market sale | 44,582 | $30.00 | 916,262 |
| 2013-05-29 | Open-market sale | 20,411 | $30.00 | 960,844 |
| 2013-05-28 | Open-market sale | 74,980 | $31.38 | 986,555 |
| 2013-05-28 | Open-market sale | 5,300 | $32.14 | 981,255 |
| 2013-05-28 | Open-market sale | 114,837 | $30.62 | 1,061,535 |
| 2013-05-22 | Open-market sale | 7,340 | $30.00 | 1,176,372 |
| 2013-05-20 | Open-market sale | 13,550 | $30.00 | 1,183,712 |
| 2013-04-24 | Open-market sale | 6,303 | $30.04 | 1,163,486 |
| 2013-04-23 | Open-market sale | 108,115 | $30.00 | 1,169,789 |
| 2013-04-15 | Open-market sale | 2,575 | $30.00 | 1,277,904 |
| 2013-04-12 | Option exercise (out-of-money) (derivative) | 37,192 | $0.00 | 0 |
| 2013-04-12 | Open-market sale | 3,416 | $29.30 | 1,314,255 |
| 2013-04-12 | Option exercise (out-of-money) | 37,192 | $2.69 | 1,317,671 |
| 2013-04-12 | Open-market sale | 10,000 | $30.00 | 1,280,479 |
| 2013-03-18 | Open-market sale | 500,000 | $28.44 | 2,290,479 |
| 2013-03-11 | Open-market sale | 500,000 | $27.86 | 2,790,479 |
| 2012-06-05 | Grant / award (derivative) | 7,000 | $0.00 | 7,000 |
| 2012-02-08 | Conversion (derivative) | 712,567 | $0.00 | 0 |
| 2012-02-08 | Conversion (derivative) | 1,487,680 | $0.00 | 0 |
| 2012-02-08 | Conversion | 712,567 | — | 2,293,227 |
| 2012-02-08 | Open-market buy | 267,857 | $7.00 | 2,561,084 |
| 2012-02-08 | Open-market buy | 267,857 | $7.00 | 2,828,941 |
| 2012-02-08 | Conversion | 1,487,680 | — | 1,580,660 |
| 2011-11-21 | Open-market buy | 461,538 | $6.50 | 3,290,479 |
| 2011-06-02 | Grant / award (derivative) | 15,692 | $0.00 | 15,692 |
| 2011-02-08 | Conversion (derivative) | 712,567 | $0.00 | 0 |
| 2011-02-08 | Conversion (derivative) | 1,487,680 | $0.00 | 0 |
| 2011-02-08 | Conversion | 712,567 | — | 2,293,227 |
| 2011-02-08 | Conversion | 1,487,680 | — | 1,580,660 |
| 2011-02-08 | Open-market buy | 267,857 | $7.00 | 2,561,084 |
| 2011-02-08 | Open-market buy | 267,857 | $7.00 | 2,828,941 |
| 2011-02-02 | — | — | — | 92,980 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.